Cited by 335Neuroinflammation and Neurodegeneration MechanismsAdvanced Glycation End Products researchAlzheimer's disease research and treatments

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

Open access

Fang, Fang, Lue, Lih-Fen, Yan, Shiqiang, Xu, Hongwei, Luddy, John S., Chen, Doris, Walker, Douglas G., Stern, David M., Yan, Shifang, Schmidt, Ann Marie, Chen, John X., Yan, Shirley ShiDu·2010·The FASEB Journal

DOI 10.1096/fj.09-139634PMC PMC3231946

Open this paper in CoChat — free account

Abstract

Microglia are critical for amyloid‐β peptide (Aβ)‐mediated neuronal perturbation relevant to Alzheimer's disease (AD) pathogenesis. We demonstrate that overexpression of receptor for advanced glycation end products (RAGE) in imbroglio exaggerates neuroinflammation, as evidenced by increased proinflammatory mediator production, Aβ accumulation, impaired learning/memory, and neurotoxicity in an Aβ‐rich environment. Transgenic (Tg) mice expressing human mutant APP (mAPP) in neurons and RAGE in microglia displayed enhanced IL‐1β and TNF‐α production, increased infiltration of microglia and astrocytes, accumulation of Aβ, reduced acetylcholine esterase (AChE) activity, and accelerated deterioration of spatial learning/memory. Notably, introduction of a signal transduction‐defective mutant RAGE (DN‐RAGE) to microglia attenuates deterioration induced by Aβ. These findings indicate that RAGE signaling in microglia contributes to the pathogenesis of an inflammatory response that ultimately impairs neuronal function and directly affects amyloid accumulation. We conclude that blockade of microglial RAGE may have a beneficial effect on Aβ‐mediated neuronal perturbation relevant to AD pathogenesis.—Fang, F., Lue, L.‐F., Yan, S., Xu, H., Luddy, J. S., Chen, D., Walker, D. G., Stern, D. M., Yan, S., Schmidt, A. M., Chen, J. X., Yan, S. S. RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. FASEB J. 24, 1043–1055 (2010). www.fasebj.org

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1096/fj.09-139634

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Self-citation
RAGE Mediates a Novel Proinflammatory Axis
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864
Self-citation
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,526
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,426
Self-citation
ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303
Self-citation
Untitled work
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
Yankner, B. A. (1996) · Neuron · doi:10.1016/s0896-6273(00)80115-4 · Cited by 953
Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease
Du, H., Guo, L., Fang, F., Chen, D., Sosunov, A. A., McKhann, G. M., Yan, Y., Wang, C., Zhang, H., Molkentin, J. D., et al. (2008) · Nature Medicine · doi:10.1038/nm.1868 · Cited by 950
Self-citation
Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease
El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915

Flagged first, then by citations

Show all 81 references

Sorted by citations

Items 201–300 of 335

An Aqueous Orally Active Vaccine Targeted Against a RAGE/AB Complex as a Novel Therapeutic for Alzheimer’s Disease
Webster, S. J., Mruthinti, S., Hill, W. D., Buccafusco, J. J., & Terry, A. V. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8176-z · Cited by 21
The combined treatment of amyloid-β1-42-stimulated bone marrow–derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice
Wang, F., Liu, H., Shen, X., Ao, H., Moore, N., Gao, L., Chen, L., Hu, H., Ma, H., Yang, Z., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.029 · Cited by 20
Shared pathological pathways of Alzheimer's disease with specific comorbidities: current perspectives and interventions
Nday, C. M., Eleftheriadou, D., & Jackson, G. E. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14256 · Cited by 21
Diaphanous 1 (DIAPH1) is Highly Expressed in the Aged Human Medial Temporal Cortex and Upregulated in Myeloid Cells During Alzheimer’s Disease
Derk, J., Bermudez‐Hernandez, K., Rodriguez, M., He, M., Koh, H., Abedini, A., Li, H., Fenyö, D., & Schmidt, A. M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180088 · Cited by 21
Self-citation
Intravitreal S100B Injection Triggers a Time-Dependent Microglia Response in a Pro-Inflammatory Manner in Retina and Optic Nerve
Grotegut, P., Kuehn, S., Meißner, W., Dick, H. B., & Joachim, S. C. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01786-4 · Cited by 20
The Impact of Aging on the Function of Retinal Ganglion Cells
Prinz, J., Walter, P., Liu, H., & Prokosch, V. (2024) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-2239-0290 · Cited by 19
T cells promote the regeneration of neural precursor cells in the hippocampus of Alzheimer′s disease mice
Da-chuan, X., Liu, J., Ma, Y., Tian, S., Zhang, L., Zhao, M., & Zhang, Y. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.139481 · Cited by 19
Modulation of RAGE Isoforms Expression in the Brain and Plasma of Rats Exposed to Transient Focal Cerebral Ischemia
Greco, R., Amantea, D., Mangione, A. S., Petrelli, F., Gentile, R., Nappi, G., Blandini, F., Corasaniti, M. T., & Tassorelli, C. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0778-1 · Cited by 19
Neurotoxic factors released by stimulated human monocytes and THP-1 cells
Lee, M., Suk, K., Kang, Y., McGeer, E. G., & McGeer, P. L. (2011) · Brain Research · doi:10.1016/j.brainres.2011.05.021 · Cited by 19
Ligands of RAGE-Proteins: Role in Intercellular Communication and Pathogenesis of Inflammation
Uspenskaya, Y. A., Komleva, Y. K., Пожиленкова, Е. А., Salmin, V. V., Lopatina, O. L., Фурсов, А. А., Вячеславович, Л. П., Belova, O. A., & Salmina, A. B. (2015) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn566 · Cited by 19
Brain Structural Alterations, Diabetes Biomarkers, and Cognitive Performance in Older Adults With Dysglycemia
Oh, D. J., Jung, J.-J., Shin, S. A., Kim, H., Park, S., Sohn, B. K., Koo, B. K., Moon, M. K., Kim, Y., & Lee, J. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.766216 · Cited by 18
LRP1 and RAGE Genes Transporting Amyloid and Tau Protein in the Hippocampal CA3 Area in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival
Pluta, R. M., Kocki, J., Bogucki, J., Bogucka‐Kocka, A., & Czuczwar, S. J. (2023) · Cells · doi:10.3390/cells12232763 · Cited by 20
Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease
Kim, D., & Priefer, R. (2020) · Brain Sciences · doi:10.3390/brainsci10020093 · Cited by 18
Genetic ablation of receptor for advanced glycation end products promotes functional recovery in mouse model of spinal cord injury
Guo, J., Li, L., Shi, Y., Wang, H., Yuan, Y., Shi, X., & Hou, S. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-1972-z · Cited by 18
Autophagy in alzheimer disease pathogenesis and its therapeutic values
Angst, G., Jia, N., Esqueda, L. T., Fan, Y., Cai, Q., & Wang, C. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2471677 · Cited by 22
Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration
Pehar, M., & Kinscherf, N. A. (2022) · Current Drug Targets · doi:10.2174/1389450123666220610171005 · Cited by 17
An overview on microglial origin, distribution, and phenotype in Alzheimer's disease
Islam, R., Choudhary, H. H., Rajan, R. G., Vrionis, F. D., & Hanafy, K. A. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30829 · Cited by 18
Contribution of hyperglycemia-induced changes in microglia to Alzheimer’s disease pathology
Rodríguez, M. H., Flores‐Clemente, C., Macías-Pérez, M. E., Rodríguez-Fonseca, R. A., Nicolás‐Vázquez, M. I., Martínez, J. O., Miranda, R., Rosas, M., & Jiménez, E. M. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00405-9 · Cited by 17
Specific serum autoantibodies predict the development and progression of Alzheimer’s disease with high accuracy
Fang, L., Jiao, B., Liu, X., Wang, Z., Yuan, P., Zhou, H., Xiao, X., Cao, L., Guo, J., Tang, B., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.11.018 · Cited by 17
Effects of RAGE inhibition on the progression of the disease in hSOD1G93A ALS mice
Liu, L., Killoy, K. M., Vargas, M. R., Yamamoto, Y., & Pehar, M. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.636 · Cited by 17
AGER genetic polymorphisms increase risks of breast and lung cancers
Yin, N., Lang, X., Wang, X. D., & Liu, W. (2015) · Genetics and Molecular Research · doi:10.4238/2015.december.22.2 · Cited by 17
Pathogenesis and therapeutic applications of microglia receptors in Alzheimer’s disease
Fu, J., Wang, R., He, J., Liu, X., Wang, X., Yao, J., Liu, Y., Ran, C., Ye, Q., & He, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1508023 · Cited by 17
Apoptotic Cell-Inspired Polymeric Particles for Controlling Microglial Inflammation toward Neurodegenerative Disease Treatment
Nakagawa, Y., Yano, Y., Lee, J., Anraku, Y., Nakakido, M., Tsumoto, K., Cabral, H., & Ebara, M. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01510 · Cited by 16
Amyloid β-Induced Inflammarafts in Alzheimer’s Disease
Ding, S., Choi, S., & Miller, Y. I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104592 · Cited by 19
Failure, Success, and Future Direction of Alzheimer Drugs Targeting Amyloid‐β Cascade: Pros and Cons of Chemical and Biological Modalities
Kim, J., Jeon, H., Kim, H. Y., & Kim, Y. S. (2023) · ChemBioChem · doi:10.1002/cbic.202300328 · Cited by 17
Microglia signaling in health and disease – Implications in sex-specific brain development and plasticity
Pramanik, S., Harini Devi, M., Chakrabarty, S., Paylar, B., Pradhan, A., Thaker, M., Ayyadhury, S., Manavalan, A., Olsson, P., Pramanik, G., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105834 · Cited by 18
The Effects of Impaired Cerebral Circulation on Alzheimer's Disease Pathology: Evidence from Animal Studies
Villarreal, A. E., Barron, R., Rao, K. S. J., & Britton, G. B. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140144 · Cited by 14
Activation of peroxisome proliferator‐activated receptor delta suppresses BACE 1 expression by up‐regulating SOCS 1 in a JAK 2/ STAT 1‐dependent manner
Lee, W. J., Ham, S. A., Lee, G. H., Choi, M., Yoo, H., Paek, K. S., Lim, D., Hong, K., Hwang, J. S., & Seo, H. G. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14715 · Cited by 13
Protection of Beta Boswellic Acid against Streptozotocin-induced Alzheimerʼs Model by Reduction of Tau Phosphorylation Level and Enhancement of Reelin Expression
Shasaltaneh, M. D., Naghdi, N., Ramezani, S., Alizadeh, L., & Riazi, G. H. (2021) · Planta Medica · doi:10.1055/a-1502-7083 · Cited by 14
Mechanism of action and therapeutic potential of S100A8/A9 in neuroinflammation and cognitive impairment: From molecular target to clinical application (Review)
Guan, X., Zha, L., Zhu, X., Rao, X., Huang, X., Xiong, Y., Guo, Y., Zhang, M., Zhou, D., Tu, Q., et al. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5588 · Cited by 14
Microglial Dysfunction and Amyloid-Beta Pathology in Alzheimer’s Disease and HIV-Associated Neurocognitive Disorders
Njoku, G. C., & Kanmogne, G. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189069 · Cited by 15
Amyloid Beta Peptide-Mediated Alterations in Mitochondrial Dynamics and its Implications for Alzheimer’s Disease
Monsalvo-Maraver, L. Á., Maya-López, M., Rangel‐López, E., Túnez, I., Tinkov, A. A., Skalny, A. V., Ferrer, B., Aschner, M., & Santamaría, A. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220616094036 · Cited by 14
Lower expression level of two RAGE alternative splicing isoforms in Alzheimer’s disease
Zhu, H., & Ding, Q. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.04.032 · Cited by 12
Tackling Alzheimer's disease: Hypothetical synergism between anti-inflammatory and anti-diabetic agents
Łuc, M., Woźniak, M., Helemejko, M., & Rymaszewska, J. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.05.039 · Cited by 12
Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge
Xu, X., Zhang, Q., Chu, X., Quan, Y., Lv, B., & Zhang, H. (2021) · Viruses · doi:10.3390/v13112117 · Cited by 12
Microglia in Alzheimer’s Disease: A Favorable Cellular Target to Ameliorate Alzheimer’s Pathogenesis
Sumsuzzman, D. M., Uddin, M. S., Kabir, M. T., Hasana, S., Perveen, A., Alanazi, I. S., Albadrani, G. M., Abdel‐Daim, M. M., & Ashraf, G. M. (2022) · Mediators of Inflammation · doi:10.1155/2022/6052932 · Cited by 12
Effect of Transient Cerebral Ischemia on the Expression of Receptor for Advanced Glycation End Products (RAGE) in the Gerbil Hippocampus Proper
Lee, J., Cho, J. H., Cho, G., Ahn, J. H., Park, J. H., Kim, I. H., Cho, J.-H., Tae, H., Cheon, S. H., Ahn, J. Y., et al. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1345-8 · Cited by 11
What Is the Role of Microglial Metabolism in Inflammation and Neurodegeneration?
Benarroch, E. E. (2022) · Neurology · doi:10.1212/wnl.0000000000200920 · Cited by 10
Receptors on Microglia
Augusto‐Oliveira, M., Tremblay, M., & Verkhratsky, A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_6 · Cited by 10
The impact of high-sugar diets on central nervous system disorders: mechanisms, pathogenesis, and dietary implication
Li, F., Luo, Q., Guo, T., Zhou, S., Cheng, Z., Pan, H., & Tu, J. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2561789 · Cited by 12
Receptor for Advanced Glycation End Products Is Involved in LPA5-Mediated Brain Damage after a Transient Ischemic Stroke
Sapkota, A., Park, S. J., & Choi, J. W. (2021) · Life · doi:10.3390/life11020080 · Cited by 10
Sesamin suppresses advanced glycation end products induced microglial reactivity using BV2 microglial cell line as a model
Udomruk, S., Wudtiwai, B., Shwe, T. H., Phitak, T., Pothacharoen, P., Phimphilai, M., & Kongtawelert, P. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.04.012 · Cited by 10
Exploiting formyl peptide receptor 2 to promote microglial resolution: a new approach to Alzheimer’s disease treatment
Wickstead, E. S., Irving, M. A., Getting, S. J., & McArthur, S. (2021) · FEBS Journal · doi:10.1111/febs.15861 · Cited by 10
Frequent Alzheimer’s disease neuropathological change in patients with glioblastoma
Greutter, L., Miller-Michlits, Y., Klotz, S., Reimann, R., Nenning, K., Platzek, S., Krause, E., Kiesel, B., Widhalm, G., Langs, G., et al. (2024) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdae118 · Cited by 10
Antiglycating effects of citrus flavonoids and associated mechanisms
Xiao, Y., Shen, J., Zhan, J., Guo, L., Ho, C., & Li, S. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250247 · Cited by 9
RAGE antagonism with azeliragon improves xenograft rejection by T cells in humanized mice.
Joshi, A. A., Wu, Y., Deng, S., Preston‐Hurlburt, P., Forbes, J. M., & Herold, K. C. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109165 · Cited by 9
Antiglycative Activity and RAGE Expression in Rett Syndrome
Cordone, V., Pecorelli, A., Benedusi, M., Santini, S. J., Falone, S., Hayek, J., Amicarelli, F., & Valacchi, G. (2019) · Cells · doi:10.3390/cells8020161 · Cited by 9
ALWPs Improve Cognitive Function and Regulate Aβ Plaque and Tau Hyperphosphorylation in a Mouse Model of Alzheimer’s Disease
Nam, Y., Joo, B., Lee, J., Han, K., Ryu, K., Koh, Y. H., Kim, J., Koo, J. W., We, Y.-M., & Hoe, H. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00192 · Cited by 9
Nexus of NFκB/VEGF/MMP9 signaling in diabetic retinopathy-linked dementia: Management by phenolic acid-enabled nanotherapeutics
Singh, V., & Panda, S. P. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123123 · Cited by 8
Extracellular matrix glycation epigenetically regulates brain aging and neurodegeneration in the in vitro aged neurovascular model
Jang, M., Lee, H., Seo, E. U., & Kim, H. N. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123504 · Cited by 8
Inflammaging
Franceschi, C., Capri, M., Garagnani, P., Ostan, R., Santoro, A., Monti, D., & Salvioli, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_45-1 · Cited by 9
Targeting memory loss with aspirin, a molecular mechanism perspective for future therapeutic approaches
Gholami, M., Sadegh, M., Koroush-arami, M., Norouzi, S., Arismani, R. J., Asadi, E., Amini, M., & Khodayari, N. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01347-1 · Cited by 8
Inhibition of MAPKs Signaling Pathways Prevents Acrolein-Induced Neurotoxicity in HT22 Mouse Hippocampal Cells
Liu, M., Huang, Y., Qin, J., Wang, Y. Y., Ke, B., & Yang, Y. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00715 · Cited by 8
Protective effects against memory impairment induced by methylglyoxal in mice co-treated with FPS-ZM1, an advanced glycation end products receptor antagonist
Szczepanik, J. C., Garcia, A. F., de Almeida, G. R. L., Cunha, M. P., & Dafré, A. L. (2020) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2020-033 · Cited by 10
Modulation of the receptor for advanced glycation end products pathway by natural polyphenols: A therapeutic approach to neurodegenerative diseases
Wei, Y., Zhang, Y., Sun, J., Li, W., Zhao, X., Tian, N., Cao, Y., & Xie, J. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105511 · Cited by 7
RAGE Exacerbate Amyloid Beta (Aβ) Induced Alzheimer Pathology: A Systemic Overview
Akhter, F., Akhter, A., Kesari, K. K., Javed, R., Ruokolainen, J., & Vuorinen, T. (2019) · Environmental science and engineering · doi:10.1007/978-3-319-96511-6_9 · Cited by 7
Plasma Concentrations of High Mobility Group Box 1 Proteins and Soluble Receptors for Advanced Glycation End-Products Are Relevant Biomarkers of Cognitive Impairment in Alcohol Use Disorder: A Pilot Study
de Fonseca, F. R., Medina-Paz, F., Sapozhnikov, M., Hurtado-Guerrero, I., Rubio, L., Martín‐de‐las‐Heras, S., Requena-Ocaña, N., Flores-López, M., Fernández‐Arjona, M. D. M., Rivera, P., et al. (2024) · Toxics · doi:10.3390/toxics12030190 · Cited by 7
Linking atherosclerosis to Alzheimer's disease: focus on biomarkers
Emanuele, E. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/411 · Cited by 7
Pro-Oxidative and Inflammatory Actions of Extracellular Hemoglobin and Heme: Molecular Events and Implications for Alzheimer's and Parkinson Disease
Campomayor, N. B., Kim, H. J., & Kim, M. (2025) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2024.224 · Cited by 8
Glial Cells as Key Mediators in the Pathophysiology of Neurodegenerative Diseases
Bogus, K., Marchesi, N., Campagnoli, L. I. M., Pascale, A., & Pałasz, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020884 · Cited by 10
Immune signaling and function in neurodegeneration
Latour, Y. L., & McGavern, D. B. (2026) · Journal of Clinical Investigation · doi:10.1172/jci199850 · Cited by 9
Network pharmacology and molecular docking to study the potential molecular mechanism of Qi Fu Yin for diabetic encephalopathy
Guo, X., Wang, F., Zheng, M., Li, L., Li, L., Wang, J., Miao, S., Ma, S., & Shi, X. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2289038 · Cited by 6
Cytotoxic role of advanced glycation end-products in PC12 cells treated with β-amyloid peptide
Yan, F., HAN, G.-L., & WU, G.-J. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1545 · Cited by 6
Synthetic fragment (60–76) of RAGE improves brain mitochondria function in olfactory bulbectomized mice
Avetisyan, A. V., Balasanyants, S. M., Simonyan, R. A., Koroev, D. O., Kamynina, A. V., Zinovkin, R. A., Бобкова, Н. В., & Volpina, O. M. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104799 · Cited by 6
The pattern recognition reagents RAGE VC1 and peptide p5 share common binding sites and exhibit specific reactivity with AA amyloid in mice
Kennel, S. J., Williams, A. D., Stuckey, A. C., Richey, T., Wooliver, C., Chazin, W., Stern, D., Martin, E. B., & Wall, J. S. (2015) · Amyloid · doi:10.3109/13506129.2015.1112782 · Cited by 6
Self-citation
Inhibition of BET proteins modulates amyloid-beta accumulation and cognitive performance in middle-aged mice prenatally exposed to maternal immune activation
Matuszewska, M., Wilkaniec, A., Gąssowska-Dobrowolska, M., Cieślik, M., Olech-Kochańczyk, G., Pałasz, E., Gawinek, E., Strawski, M., & Czapski, G. A. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1619583 · Cited by 6
Redox-sensitive high mobility group box 1 (HMGB1) protein is a multipotent regulator in the pathogenesis of Alzheimer's disease
Salminen, A. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106115 · Cited by 5
Adenosine Receptors and Alzheimer’s Disease
Blum, D. L., Sandau, U. S., Laurent, C., Batalha, V. L., Leboucher, A., Hamdane, M., Pasquier, F., Boison, D., Buée, L., & Lopes, L. V. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3903-5_19 · Cited by 6
Genetic association between RAGE polymorphisms and Alzheimer's disease and Lewy body dementias in a Japanese cohort: a case–control study
Takeshita, Y., Shibata, N., Kasanuki, K., Nagata, T., Shinagawa, S., Kobayashi, N., Ohnuma, T., Suzuki, A., Kawai, E., Takayama, T., et al. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4600 · Cited by 5
The Roles of S100 Proteins and RAGE in Melanoma
Leclerc, E. (2011) · InTech eBooks · doi:10.5772/18899 · Cited by 5
Inflammaging
Franceschi, C., Capri, M., Garagnani, P., Ostan, R., Santoro, A., Monti, D., & Salvioli, S. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_45 · Cited by 6
RAGE signaling pathway in glioblastoma and cognitive decline: Insights into inflammatory mechanisms and therapeutic implications
Raj, J. A. T., John, G., Ghanekar, S., Thiruselvan, G. K., Shah, J., Ande, D., Chatterjee, A., & Goda, J. S. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150026 · Cited by 6
Ligature-induced periodontitis in a transgenic mouse model of Alzheimer's disease dysregulates neuroinflammation, exacerbates cognitive impairment, and accelerates amyloid pathology
Jimenez-Harrison, D., Butler, M. J., Ijaz, H., Alsabbagh, R., Bettes, M. N., DeMarsh, J. W., Mackey-Alfonso, S. E., Muscat, S. M., Alvarez, B. D., Blackwell, J. A., et al. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.100969 · Cited by 4
Contribution of Diabetes and Metabolic Syndrome in the Pathogenesis of Alzheimer’s Disease
Farooqui, A. A., & Farooqui, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811959-4.00019-5 · Cited by 4
Metabolic Syndrome as a Risk Factor for Alzheimer Disease
Farooqui, A. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7318-3_8 · Cited by 5
Neurobiological Mechanisms of Cognitive Decline Correlated with Brain Aging
Zhang, X., An, H., Chen, Y., & Shu, N. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-1627-6_10 · Cited by 4
Acute MDPV Binge Paradigm on Mice Emotional Behavior and Glial Signature
Campeão, M. M. S., Fernandes, L., Pita, I. R., Lemos, C., Ali, S. F., Carvalho, F. D., Rodrigues‐Santos, P., Ribeiro, C., Soares, E. F. P., Viana, S., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14030271 · Cited by 3
Glucose- and Fructose-Induced Toxicity in the Liver and Brain
Farooqui, A. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7318-3_2 · Cited by 3
Diabetes Associated Memory Impairment: Perspective on Management Strategies
Sharma, G., Sonu, & Harikumar, S. (2015) · International journal of pharma research and review · Cited by 3
A novel hybrid protein promotes Aβ clearance and reduces inflammatory response through MerTKPreprint
Samentar, L., Salazar, A., Pan, P., Etebar, K., Choy, K., Uddin, D., Eliseeff, P., Bugayong, A. M., Garrido, J. A. M. G., Emini, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.03.467048 · Cited by 2
Traditional Chinese Medicine Natural Products Targeting Shared Mechanisms of T2DM and AD: Potential Therapeutic Insights
Song, B., Yue, D., Yan, H., Feng, L., & Li, M. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s531909 · Cited by 3
More than Dysbiosis: Imbalance in Humoral and Neuronal Bidirectional Crosstalk Between Gut and Brain in Alzheimer’s Disease
Г.Т., Т., Zholdassova, M., Novosolova, N., Malm, T., Giniatullin, R. A., & Kustubayeva, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010369 · Cited by 4
Machine learning based prediction of cognitive metrics using major biomarkers in SuperAgers
Lee, H., Kwon, S., Park, J.-H., Kim, B. R., Kim, G. H., Choi, J., & Park, Y. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-01477-2 · Cited by 2
Neurochemical Effects of Long Term Consumption of Simple Carbohydrates
Farooqui, A. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-15254-7_3 · Cited by 2
Aβ42-α7-like nicotinic acetylcholine receptors and Alzheimer’s disease
Wang, H.-Y., & Khan, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00029-3 · Cited by 2
Innate Immune Signaling and Alcoholism
Vetreno, R. P., & Crews, F. T. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_8 · Cited by 2
Assessment of the Level of Rage in Cells Blood-Brain Barrier in Experimental Alzheimer’s Disease
Gorina, Y. V., Osipova, E. D., Morgun, A. V., Boytsova, E. B., Lopatina, O. L., & Salmina, A. B. (2021) · Cell and Tissue Biology · doi:10.1134/s1990519x21030032 · Cited by 2
Biologically Active Fragment of the Receptor for Advanced Glycation End Products (RAGE) Is Able to Inhibit Oligomerization of the Beta-Amyloid
Volkova, T. D., Avetisyan, A. V., Koroev, D. O., Kamynina, A. V., Balasanyants, S. M., Simonyan, R. A., & Volpina, O. M. (2022) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162022040197 · Cited by 1
Shortened PGLYRP1 Peptides Regulate Antitumor Activity of Cytotoxic Lymphocytes via TREM-1 Receptor: From Biology to Bioinformatics
Yurkina, D. M., Shcherbakov, K. A., Romanova, E. A., Tvorogova, A. V., Feoktistov, A. M., Georgiev, G. P., Yashin, D. V., & Sashchenko, L. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094069 · Cited by 1
The metabolic roots of memory loss: interlinking the Diabetes-Alzheimer’s hypothesis
Gupta, T., Kumar, S., Singh, T. G., & Singh, R. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01824-w · Cited by 1
Is amyloid beta peptide a driver of inflammaging?
Kechko, O. I., Moskalev, A. A., Franceschi, C., Mitkevich, V. A., & Makarov, A. А. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103280 · Cited by 1
Molecular Aspects of Obesity and Insulin Resistance in Metabolic Syndrome and Neurological Disorders
Farooqui, A. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7318-3_5 · Cited by 1
The CNS Innate Immune System and the Emerging Roles of the Neuroimmune Regulators (NIRegs) in Response to Infection, Neoplasia and Neurodegeneration
W., J., Denizot, M., J., J., & Gasque, P. (2012) · InTech eBooks · doi:10.5772/37824 · Cited by 1
Contribution of Dietary Carbohydrates in Induction of Oxidative Stress
Farooqui, A. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-04111-7_8 · Cited by 2
Genetic ablation of receptor for advanced glycation end products promotes functional recovery in mouse model of spinal cord injury
LiYa-min, J.-D. G. (2014) · Cited by 1
Novel Somatostatin Receptor Subtype‐4 Agonist Mitigates Microglia Inflammatory Activation
Silwal, A., Mobayen, S., Crider, A. M., Neumann, W. L., House, A., Umbaugh, D. S., Bhandari, S., Sandoval, K. E., & WITT, K. A. (2019) · The FASEB Journal · doi:10.1096/fasebj.2019.33.1_supplement.501.3 · Cited by 1
New Insights into Microglia as Therapeutic Targets in Alzheimer’s Disease
Mandlik, D. S., Mandlik, S. K., & Choudhary, H. B. (2023) · Current Drug Therapy · doi:10.2174/1574885518666230427100702 · Cited by 2
Efeito do glicolaldeído sobre parâmetros de estresse oxidativo no rim, fígado e coração de ratos Wistar
Lorenzi, R. (2010) · Americanae (AECID Library)
Roles of different glial populations in neuronal maturation: implications in Rett Syndrome and Alzheimer's disease
Mastrangelo, R. (2015) · OpenstarTs (Univeristy of Trieste https://www.units.it/)
99mTc-Labeled anti-receptor for advanced glycation endproducts monoclonal antibody F(ab’)2 fragments
Shan, L. (2010) · Europe PMC (PubMed Central)

Authors: Fang, F., Lue, L.-F., Yan, S., Xu, H., Luddy, J. S., Chen, D., Walker, D. G., Stern, D. M., Yan, S., Schmidt, A. M., Chen, J. X., & Yan, S. S.
Affiliations: Columbia University Irving Medical Center (US)
Banner Sun Health Research Institute (US)
Harbin Medical University (CN)
University of Cincinnati (US)
Department of Surgery College of Physicians and Surgeons Columbia University New York New York USA
Memorial Sloan Kettering Cancer Center (US)
Corresponding author: Yan, Shirley ShiDu
ORCID: Lue, Lih-Fen
Yan, Shiqiang
Xu, Hongwei
Chen, Doris
Walker, Douglas G.
Schmidt, Ann Marie
Venue: The FASEB Journal
Publisher: Wiley
Published: 2009-11-11
Volume: 24
Issue: 4
Pages: 1043-1055
ISSN: 0892-6638 (ISSN-L)
1530-6860
DOI: 10.1096/fj.09-139634
PMC: PMC3231946
OpenAlex: W2054082659
Cited by: 335
References: 81
Citations by year: 2026: 20 · 2025: 23 · 2024: 14 · 2023: 16 · 2022: 23 · 2021: 32 · 2020: 21 · 2019: 18 · 2018: 7 · 2017: 16 · 2016: 23 · 2015: 25 · 2014: 30 · 2013: 19 · 2012: 24
FWCI: 10.25
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: The FASEB Journal (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Public Health Service (PO1AG17490)
Arizona Alzheimer’s Consortium
Topics: Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: receptor for advanced glycation end products, RAGE signaling, microglia, neuroinflammation, amyloid-beta deposition, Alzheimer's disease, learning and memory impairment, IL-1β, TNF-α, acetylcholinesterase activity, APP transgenic mice, neurotoxicity
MeSH terms: Receptor for Advanced Glycation End Products, Alzheimer Disease, Animals, Astrocytes, Disease Models, Animal, Humans, Inflammation, Learning, Memory, Mice, Transgenic, Mutation, Neurons, Tumor Necrosis Factor-alpha, Signal Transduction, Amyloid beta-Peptides, Microglia, Mitogen-Activated Protein Kinases, Mice, Interleukin-1beta

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks